Physician profile
Craig E Singer
NPI 1255332771
$16,557.62
in general payments reported to CMS, 2019-2025
40 companies · $3,038 in 2025
The $3,038 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $1,186 · 2021: $1,876 · 2022: $3,656 · 2023: $2,352 · 2024: $3,208 · 2025: $3,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,323 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,323.13 |
| Education | $275.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,485.26 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $2,106.37 | 2019-2025 | Rinvoq, Skyrizi |
| Biofrontera INC. | $1,733.47 | 2022-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Genzyme Corporation | $1,587.85 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,398.51 | 2019-2025 | Winlevi, Ilumya, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $942.66 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $862.85 | 2019-2025 | Dupixent, Libtayo |
| Pfizer INC. | $669.64 | 2019-2025 | |
| Lilly USA, LLC | $538.38 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $426.96 | 2019-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $388.93 | 2019-2025 | Nemluvio, Aklief |
| Ucb, INC. | $359.47 | 2019-2025 | Bimzelx |
| Dermavant Sciences, INC. | $345.28 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $340.99 | 2019-2024 | Jublia |
| Incyte Corporation | $319.59 | 2021-2025 | Opzelura |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.